Foresight invests £3M into global healthcare software provider NorthWest EHealth
Summary
Its products provide the life sciences industry with an alternative approach to clinical trial design and management. The investment will be used to expand the current data network, enabling the Company to deliver a larger number of trials at a global level, increase product development and expand the sales and marketing team to help build long term, strategic relationships. The existing team have strong credentials in their field and are led by founder and CEO Martin Gibson. Customers include several of the largest global pharmaceutical and research companies, such as GSK, Novartis and PPD. The market opportunity is vast, with global clinical trials estimated to be worth $69 billion annually and forecast to grow at a rate of 5.7% per year until 2026.